The David Rubenstein Show: Eli Lilly CEO Dave Ricks

Eli Lilly is the world's most valuable drug company, known for its blockbuster anti-obesity drugs that's transforming America. On "The David Rubenstein Show: Peer to Peer Conversations," CEO Dave Ricks talks about how the company will begin studies this year to see if its weight-loss medicines can also be used to treat addictive behaviors. He also discusses how the company is tackling the issue of counterfeit drugs. This interview was recorded December 10 at the Economic Club of Washington DC.

Chapters:
00:01:10 - Zepbound
00:05:30 - Obesity in the US
00:07:39 - Will there be a pill?
00:10:23 - The History of Eli Lilly
00:11:55 - Future Products
00:18:28 - Counterfeit Drugs
--------
Like this video? Subscribe to The David Rubenstein Show on YouTube:
/ @davidrubenstein

Watch the latest episodes of "The David Rubenstein Show: Peer-to-Peer Conversations" here:
https://www.bloomberg.com/peer-to-peer

Learn more about David:
http://www.davidrubenstein.com/
Connect with us on...
Twitter: / business
Facebook: / bloombergbusiness
Instagram: / bloombergbusiness